BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32821090)

  • 1. Effect of IL-6 and hsCRP Serum Levels on Functional Prognosis in Stroke Patients Undergoing IV-Thrombolysis: Retrospective Analysis.
    Pawluk H; Grześk G; Kołodziejska R; Kozakiewicz M; Woźniak A; Grzechowiak E; Szumny M; Sobolewski P; Bieniaszewski L; Kozera G
    Clin Interv Aging; 2020; 15():1295-1303. PubMed ID: 32821090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
    Lei YS; Li H; Lei JY; Li SX; Li DF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of cerebral microbleeds on outcomes of acute ischemic stroke treated with intravenous thrombolysis].
    Yan SQ; Wan JP; Guo Y; Lou M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jan; 43(1):20-7. PubMed ID: 24616457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke.
    Bunevicius A; Kazlauskas H; Raskauskiene N; Mickuviene N; Ndreu R; Corsano E; Bunevicius R
    Neuroimmunomodulation; 2015; 22(6):365-72. PubMed ID: 25967464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mean platelet volume on admission predicts unfavorable stroke outcomes in patients treated with IV thrombolysis.
    Staszewski J; Pogoda A; Data K; Walczak K; Nowocień M; Frankowska E; Stępień A
    Clin Interv Aging; 2019; 14():493-503. PubMed ID: 30880930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.
    Walters MR; Muir KW; Harbison J; Lees KR; Ford GA
    Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of functional outcome in patients with stroke thrombolysis in a tertiary hospital in Malaysia.
    Tai MLS; Goh KJ; Kadir KAA; Zakaria MI; Yap JF; Tan KS
    Singapore Med J; 2019 May; 60(5):236-240. PubMed ID: 30488077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Immune-Inflammation Index Predicts 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
    Weng Y; Zeng T; Huang H; Ren J; Wang J; Yang C; Pan W; Hu J; Sun F; Zhou X; Qiu H; Gao Y; Gao B; Chi L; Chen G
    Clin Interv Aging; 2021; 16():877-886. PubMed ID: 34040364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral thrombolysis in patients with ischemic stroke and heart failure.
    Sobolewski P; Kozera G; Szczuchniak W; Sobota A; Chwojnicki K; Gruchała M; Nyka WM
    Neurol Neurochir Pol; 2018; 52(5):593-598. PubMed ID: 30170703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic thrombolysis in ischaemic stroke patients with COVID-19.
    Sobolewski P; Antecki J; Brola W; Fudala M; Bieniaszewski L; Kozera G
    Acta Neurol Scand; 2022 Jan; 145(1):47-52. PubMed ID: 34415051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
    Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
    Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
    Rusanen H; Saarinen JT; Sillanpää N
    Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal cerebral vein asymmetry on follow-up brain computed tomography after intravenous thrombolysis in acute anterior circulation ischemic stroke is associated with poor outcome.
    Sharma VK; Yeo LL; Teoh HL; Shen L; Chan BP; Seet RC; Ahmad A; Chong VF; Paliwal PR
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):e39-45. PubMed ID: 24119628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea Pretreatment and In-Hospital Use Does Not Impact Acute Ischemic Strokes (AIS) Outcomes Following Intravenous Thrombolysis.
    Tsivgoulis G; Goyal N; Iftikhar S; Zand R; Chang JJ; Elijovich L; Alexandrov AW; Malkoff MD; Alexandrov AV
    J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):795-800. PubMed ID: 27865697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.
    Smith CJ; Hulme S; Vail A; Heal C; Parry-Jones AR; Scarth S; Hopkins K; Hoadley M; Allan SM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
    Stroke; 2018 May; 49(5):1210-1216. PubMed ID: 29567761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.